( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



Dr. Divyashree N.*, Shahana T. P. and Shamsia Sahar.


Background: Ear, nose and throat (ENT) infections are prevalent clinical issues that affect the general population and are a significant contributor to morbidity and senility. A further impairment of balance is caused by ear problems. Nasal conditions can alter the features of the face and make it difficult to breathe and taste. Airway patency may be at risk and speech may be hampered by diseases of the throat. Acute and chronic suppurative otitis media, upper respiratory tract infections, and other ENT conditions are frequent. Antimicrobials, among other medications, are used to treat ENT conditions; nevertheless, improper antibiotic use is a serious issue because it can result in the emergence of drug resistance. In order to reduce its side effects and maximize its therapeutic value, it becomes necessary to modify prescription patterns over time and to change usage habits accordingly. Therefore, the purpose of this study is to review the medications that the ENT department physician at a Tertiary Care Hospital prescribes. Objective: To outline the drug use trends in the Mandya, Karnataka, tertiary care hospital's ENT outpatient department (OPD). Methodology: A cross-sectional study was conducted. The research took place for around six months. Patients who visited the ENT OPD and met the inclusion criteria had their pertinent data obtained from their prescriptions. Results: The ENT Outpatient Department of the MIMS Teaching Hospital in Mandya conducted this investigation. 240 ENT department visitors who met the inclusion and exclusion criteria were included in the study. The information required from the patient's prescription was entered into an accurate patient profile form. Among the 240 patients, 114 (47.50%) were men and 126 (52.50%) were women. In accordance with this study, females are more likely than males to encounter ENT illnesses. In our research, patients between the age of 18 and 29 represented the majority of patients who visited the ENT department, with 65 (27.08%), followed by patients between the ages of 30 and 39 with 54 (22.5%), 40 to 49 with 47 (19.58%), 50 to 59 with 38 (15.84%), and those over 60 with 36 (15%). When the symptoms were investigated, 83 people reported throat pain, 65 reported ear pain, 58 reported discharge from the ears, 27 reported a cold or nasal obstruction and so on. Acute pharyngitis was the most frequent diagnosis, followed by acute suppurative otitis media (19.1%) and chronic suppurative otitis media (12.6%). Allergic Rhinitis (11.25%), Acute Rhinitis (10.83%), Acute Tonsillitis(6.25%), Otomycosis (3.33%),Otitis externa (2.91%),Acute Pharyngotonsiliitis (2.5%), Acute Rhinosinusitis(2.08%), Chronic Rhinosinusitis(1.66%), while the least common diagnoses were Allergic Rhinosinusitis (0.83%), Chronic Tonsillitis (0.83%), Acute Laryngitis (0.83%). Amoxicillin+Clavulanate was found to be the most frequently prescribed antibiotic (49.24%), followed by Cefixime (32.49%), Cefadroxil (7.11%), Ciprofloxacin (5.08%), Azithromycin (2.52%), Metronidazole, Cefpodoxime, and Mupirocin (1.02%), and Linezolid (0.50%) was found to be the least frequently prescribed antibiotic. Conclusion: Our study focuses primarily on the prescription practices and drug usage in the otorhinolaryngology department of our hospital. Specifically, it focused on the percentage of each class of antibiotics that were administered, the antibiotic combinations that were prescribed, and the medications that were prescribed for each type of organ infection. Most medications were prescribed by their generic names and given to patients at no cost by the hospital pharmacy, which is a positive development that should be commended. The WHO Essential medicine list, India 2021, included almost all of the medications supplied in oral formulation. In the study populations, steroid prescriptions were less common. This is a very positive development. Therefore, ongoing educational initiatives like pharmacovigilance sensitization by the medical college's pharmacology department may further encourage sane prescription.

Keywords: Antibiotic, ENT, Drug utilization pattern.

[Full Text Article]




    December issue has been successfully launched on December 2023.

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 December 2023 Issue has been Published, Kindly check it on

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia